# Gene Expression Profile After Gonadotropin Releasing Hormone (GnRH) Agonist Trigger of Oocyte Maturation

> **NCT01606709** · PHASE4 · TERMINATED · sponsor: **UConn Health** · enrollment: 7 (actual)

## Conditions studied

- Endometrial Receptivity
- Ovarian Hyperstimulation Syndrome

## Interventions

- **DRUG:** GnRH agonist
- **DRUG:** hCG

## Key facts

- **NCT ID:** NCT01606709
- **Lead sponsor:** UConn Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-04
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Difficult to recruit patients
- **Last updated:** 2018-11-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01606709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01606709, "Gene Expression Profile After Gonadotropin Releasing Hormone (GnRH) Agonist Trigger of Oocyte Maturation". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01606709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*